Physician profile
Brian DO
NPI 1649818782
$3,502.53
in general payments reported to CMS, 2019-2025
19 companies · $2,740 in 2025
The $2,740 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $763 · 2025: $2,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,502.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,132.09 | 2024-2025 | |
| Incyte Corporation | $530.40 | 2024-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $317.32 | 2024-2025 | |
| Ucb, INC. | $304.52 | 2024-2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $270.31 | 2024-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $131.75 | 2024-2025 | |
| Lilly USA, LLC | $124.39 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $114.95 | 2025 | |
| Galderma Laboratories, L.P. | $89.88 | 2024-2025 | Nemluvio |
| Cipher Pharmaceuticals US LLC | $89.47 | 2025 | Spinosad, Natroba |
| Organon LLC | $83.70 | 2025 | |
| Botanix Sb INC | $73.94 | 2025 | Sofdra |
| Mayne Pharma Commercial LLC | $59.51 | 2024-2025 | |
| Dermavant Sciences, INC. | $45.72 | 2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.22 | 2025 | Cabtreo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $28.72 | 2025 | Adbry |
| Verrica Pharmaceuticals INC. | $25.18 | 2025 | Ycanth |
| Regeneron Healthcare Solutions, INC. | $21.16 | 2025 | Libtayo |
| Journey Medical Corporation | $18.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.